Ever since the discovery of enantioselective organocatalytic Michael addition reactions, it has emerged as a significant path for synthesizing a variety of stereochemical products under mild conditions, also a prominent C−X (X=C, O, N, S) bond formation reaction in organic chemistry. Over time, substantial progress has been accomplished in diversity‐ and target‐ oriented asymmetric Michael addition reactions. This review provides a brief overview of the results, scope, and limitations of several influential strategies involving enantio‐selective Michael addition reactions promoted by mono‐functional proline/prolinol/supported‐proline‐based chiral organocatalysts. Furthermore, we also sincerely believe that the various synthetic strategies documented in this review will pave a pathway to improve the status of Michael addition reactions for synthesizing various drug molecules involving complex intermediates.